Novis PR, Inc.

FDA Regulatory Profile

Novis PR, Inc. appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1395-2019, Class I) was initiated on May 28, 2019.

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1395-2019Class IPecgen DMX Cough Suppressant Expectorant, Contains the same active ingredients as Trispec DMX, SugarMay 28, 2019